Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Parisi

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Microorganisms|March 6, 2021
HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian CohortVincenzo Malagnino, Elisabetta Teti, Mirko Compagno, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
Fish Oil Containing Pro-Resolving Mediators Enhances the Antioxidant System and Ameliorates LPS-Induced Inflammation in Human Bronchial Epithelial CellsAlfio Distefano, Laura Orlando, Sebastiano Giallongo, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2025
Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experienceIlaria Capasso, Emanuele Perrone, Simona Duranti, et al.
Viruses|January 21, 2023
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian CohortVincenzo Malagnino, Romina Salpini, Elisabetta Teti, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2025
ENDOESTRO score: Where is the dark side? Evaluation of estrogen receptor expression cutoff in endometrial cancer molecular classification, an ambispective studyEmanuele Perrone, Ettore Distefano, Emilia Palmieri, et al.
Journal of Global Antimicrobial Resistance|July 23, 2017
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitorsSamantha Andreis, Monica Basso, Renzo Scaggiante, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 9, 2025
Comparing large language models for antibiotic prescribing in different clinical scenarios: author's responseAndrea De Vito, Nicholas Geremia, Davide Fiore Bavaro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2026
Comparing large language models for antibiotic prescribing: an updated analysis using the same clinical benchmarkAntonio Russo, Nicholas Geremia, Davide Fiore Bavaro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 20, 2025
Comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better?Andrea De Vito, Nicholas Geremia, Davide Fiore Bavaro, et al.
BMC Infectious Diseases|September 20, 2014
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antiviralsAlessio Strazzulla, Chiara Costa, Vincenzo Pisani, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Microorganisms|March 6, 2021
HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian CohortVincenzo Malagnino, Elisabetta Teti, Mirko Compagno, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
Fish Oil Containing Pro-Resolving Mediators Enhances the Antioxidant System and Ameliorates LPS-Induced Inflammation in Human Bronchial Epithelial CellsAlfio Distefano, Laura Orlando, Sebastiano Giallongo, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2025
Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experienceIlaria Capasso, Emanuele Perrone, Simona Duranti, et al.
Viruses|January 21, 2023
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian CohortVincenzo Malagnino, Romina Salpini, Elisabetta Teti, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2025
ENDOESTRO score: Where is the dark side? Evaluation of estrogen receptor expression cutoff in endometrial cancer molecular classification, an ambispective studyEmanuele Perrone, Ettore Distefano, Emilia Palmieri, et al.
Journal of Global Antimicrobial Resistance|July 23, 2017
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitorsSamantha Andreis, Monica Basso, Renzo Scaggiante, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 9, 2025
Comparing large language models for antibiotic prescribing in different clinical scenarios: author's responseAndrea De Vito, Nicholas Geremia, Davide Fiore Bavaro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2026
Comparing large language models for antibiotic prescribing: an updated analysis using the same clinical benchmarkAntonio Russo, Nicholas Geremia, Davide Fiore Bavaro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 20, 2025
Comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better?Andrea De Vito, Nicholas Geremia, Davide Fiore Bavaro, et al.
BMC Infectious Diseases|September 20, 2014
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antiviralsAlessio Strazzulla, Chiara Costa, Vincenzo Pisani, et al.
Pageof 13